CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,356,058
- in 4 filings, $18.4M under 10b5-1 plans
Net −$18,356,058. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-11 | Stewart Murray Chief Medical Officer | Grant or award · Restricted Stock Units | +9,375 | 9,375 | ||
| 2021-02-11 | Stewart Murray Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +56,250 | 56,250 | ||
| 2020-06-30 | Stewart Murray Chief Medical Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 |
Page 1 of 1 · 3 trades